Announced

Completed

Premier Partners led a $15m round in Celltrio.

Synopsis

Premier Partners, an investor in healthcare innovation, led a $15m round in Celltrio, a life sciences company delivering advanced automation solutions for cell culturing and cell and gene therapy. "We are highly impressed by Celltrio’s customer traction and its differentiated intellectual property in cell culturing and cell & gene therapy automation. We believe Celltrio is poised to become a category-defining leader, delivering scalable, sterile automation to laboratories and manufacturing facilities worldwide," Jay Song, Premier Partners CEO.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite